FDA inspection
Surmasis Pharmaceutical, LLC: FDA inspection ending Mar 1, 2018
FDA inspection 1042777 · Official Action Indicated (OAI) · Des Moines, IA
Key facts
| Inspection ID | 1042777 |
|---|---|
| Firm | Surmasis Pharmaceutical, LLC |
| FEI number | 3011596846 |
| Address | 4020 Gannett Ave |
| City | Des Moines |
| State | IA |
| ZIP | 50321 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | Mar 1, 2018 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 553686 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data